SJS Investment Consulting’s ClearPoint Neuro CLPT Stock Holding History

SJS Investment Consulting’s Portfolio CLPT Stock Details CLPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$304	Buy	+17	New	+$212	﹤0.01%	2395

Other funds holding CLPT

Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return

Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Commonwealth Equity Services

Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return

Lodestone Wealth Management Spokane, Washington $283M AUM 33.76% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

New York State Common Retirement Fund

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.39B AUM 31.21% 1-Year Est. Return

Versant Capital Management Phoenix, Arizona $1.12B AUM 34.21% 1-Year Est. Return

City State Bank Norwalk, Iowa $436M AUM 32.32% 1-Year Est. Return

Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return

SJS Investment Consulting's CLPT Position: Q2 2026 in Review

SJS Investment Consulting opened a new position in ClearPoint Neuro (CLPT) in Q2 2026: 17 shares worth $304. The stake represents ﹤0.01% of the portfolio and ranks #2395 among its holdings.

22 funds tracked by Wall St. Rank hold CLPT as of Q2 2026.

SJS Investment Consulting held 17 shares of ClearPoint Neuro worth $304 as of Q2 2026.
ClearPoint Neuro was a new SJS Investment Consulting position in Q2 2026.
ClearPoint Neuro made up ﹤0.01% of SJS Investment Consulting's portfolio in Q2 2026, its #2395 holding.
22 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2026.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.